The Impact of Contrast Enhancement in Evaluating Left Ventricular Function Learn how according to the Zhao 2018 publication in the Journal of the American Society of Echocardiography contrast-enhanced echocardiography has the greatest impact in patients with reduced ejection fractions. This is a product promotional program.	The Value of Contrast in Echocardiography Learn about the growth of populations that are difficult to image, society recommendations for the use of an ultrasound enhancing agent (UEA) for suboptimal image quality, and discuss key publications on the impact of UEA use. This is a product promotional program.
Ultrasound Enhancing Agents Webinar Dr. Yuchi Han from the University of Pennsylvania presents the physics of microbubbles and how they enhance ultrasound scans, the impact of contrast in out-patient patients with reduced ejection fraction and the clinical management, plus a detailed discussion of her latest publication in the Journal of the American Society of Echocardiography (JASE). This is a product promotional program.	A Clear Path Forward – Optison Overview Attend this program to learn foundational information about Optison including case studies and its clinical utility in technically difficult studies. This is a product promotional program.
eCourse Module 1: An Introduction to Ultrasound Enhancing Agents Ultrasound enhancing agents (UEAs) have been available for decades, yet clinical adoption is lower than what society guidelines recommend. This interactive didactic lecture provides an introduction to UEAs presented by Dr. Feinstein who developed the first UEA for use in echocardiology. The module covers foundational information on what UEAs are and why they are used, and well as regulatory updates and what the data reveals about the use of UEAs. Clinical case studies and interactive CheckPoints reinforce key concepts, aiding in maximum retention of the content presented. This is a product promotional program.	eCourse Module 2: Understanding and Overcoming Barriers to Ultrasound Enhancing Agent Utilization This module begins by illustrating the benefit of Ultrasound Enhancing Agents (UEAs) followed by a discussion of the frequent barriers that prevent the utilization of UEAs on patients who would benefit clinically, and methods to overcome those barriers. Also included is a discussion of how to train your team to increase appropriate UEA usage, how to get UEAs on the formulary at your institution, and ensuring you have the appropriate billing in place. This is a product promotional program.
eCourse Module 3: Appropriate Patients for the use of Ultrasound Enhancing Agents This module, presented by Jessica Canzolino, reviews a series of clinical cases and multiple published studies with the objective of identifying patients who would most benefit from the use of UEAs. Appropriately identifying these patients early in the process can result in a reduction of inconclusive studies, quicker studies with improved accuracy, a reduction in struggle time, and may help to reduce musculoskeletal injury to the sonographer. This is a product promotional program.	Optison Case Studies Series II Teach through engaging the audience in case study reviews a variety of patient types that had suboptimal echocardiograms and how Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) was instrumental in opacifying the left ventricle and delineating endocardial borders. This is a product promotional program.
ASE 2021 Symposium: The Impact of Sonographer-Driven Contrast Administration Protocols on Efficiency and Diagnostic Utility Support for utilizing ultrasound enhancing agents (UEAs) in echocardiography is strong. Yet many institutions face a variety of challenges utilizing it as frequently as societies recommend. Join our presenters to hear about two recently published studies looking at efficiencies and diagnostic utility of a sonographer-initiated UEA administration protocol, tips from the recently released “Ultrasound Enhancing Agents: Recommended Laboratory Practices from ASE,” and insights into how their institution overcame challenges and achieved efficiencies plus diagnostic utility. This is a product promotional program.	What Echo Labs Need to Know About PEG Polyethylene glycol (PEG) is a common inactive ingredient in a wide array of consumer and medical products, including mRNA COVID vaccines, some ultrasound enhancing agents (UEAs), and certain over-the-counter laxatives. While hypersensitivity to PEG is rare, it requires acute management when it occurs. In this webinar, echocardiologist Dr. Richard L. Weiss and sonographer Rodney T. Jefferson will deepen your knowledge of PEG, discuss how to screen patients for PEG hypersensitivity, recognize its allergy-like symptoms and manage hypersensitivity when it occurs. This is a product promotional program.